AxoGen Stock PerformanceShares of AxoGen stock traded up $1.64 during trading hours on Wednesday, reaching $42.79. Following the sale, the director owned 93,826 shares in the company, valued at approximately $3,996,987.60. Insiders sold a total of 29,041 shares of company stock valued at $1,268,792 in the last quarter. Invesco Ltd. now owns 189,345 shares of the medical equipment provider’s stock valued at $6,197,000 after purchasing an additional 87,622 shares during the period. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $46.50.